Michael Asbach,

DMSc, PA-C, Psych-CAQ

Michael Asbach

DMSc, PA-C, Psych-CAQ

Associate Director, Interventional Psychiatry, DENT Neurologic Institute

Michael Asbach,

DMSc, PA-C, Psych-CAQ

Associate Director, Interventional Psychiatry, DENT Neurologic Institute

Michael Asbach is the Associate Director of Interventional Psychiatry at DENT Neurologic Institute. He is a clinical professor of psychiatry at Daemen College, D’Youville University, and Rochester Institute of Technology. Dr. Asbach received his master’s in physician assistant studies from Daemen College. His Doctorate of Medical Science degree is with a concentration in healthcare leadership. Dr. Asbach is a member of the American Academy of Physician Assistants and the Association of Physician Assistants in Psychiatry, and he serves as the Chair of Industry Relations for the New York State Society of Physician Assistants. Dr. Asbach is a nationally recognized educator who has provided over 400 lectures on behalf of the pharmaceutical industry and medical education companies.

Michael's Shared Resources

Shedding Light on Tardive Dyskinesia: A Video Discussion With Michael Asbach

In a recent interview, hosted by Matthew Shapiro and Haley Amering, they welcomed Dr. Michael Asbach to discuss tardive dyskinesia...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Professional and Social Stigma Faced by Individuals With Tardive Dyskinesia Movements, Study Reveals

Researchers of a recent study aimed to understand the impact of tardive dyskinesia (TD) on people's perceptions in professional and...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Study Highlights Risk Factors and Antipsychotic Use Patterns in Patients With Bipolar Disorder and Tardive Dyskinesia

In a recent study, researchers aimed to understand the effects and patterns of tardive dyskinesia (TD+) on the quality of...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Unraveling Tardive Syndrome: Involuntary Movements and Sensory Complaints Persist Despite New Antipsychotic Drugs

Researchers in a recent study gathered information on tardive syndrome (TS) as TS continues to persist despite the availability of...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Study Uncovers Neural Network Vulnerability in Tardive Dyskinesia’s Orofacial Symptoms

In a recent study, researchers aimed to understand why tardive dyskinesia (TD) often exhibits orofacial symptoms, while also exploring the...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

TD Frequency and Antipsychotics

Researchers of a study examined the incidence of tardive dyskinesia (TD) between long-acting injectable antipsychotics (LAI-APs) and equivalent oral antipsychotics...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Share